Dora Akunyili’s war on fake drugs — lessons for Kenya’s pharmacies
Key points
- Nation.Africa revisits how Dora Akunyili confronted Nigeria’s counterfeit-drug crisis.
- Her campaign mixed personal tragedy, regulatory toughness and public education.
- Kenya’s pharmacy chains and border trade still face falsified-medicine risks.
Counterfeit drugs kill quietly. A Nation.Africa feature revisits how Dora Akunyili drove a clean-up of Nigeria’s falsified-medicine epidemic — a story of personal loss, institutional courage and relentless public messaging that still travels across African regulatory debates.
Akunyili’s NAFDAC years became a continental reference point: seize bad stock, shame traffickers, educate patients to check packaging, and refuse political cover for poison in blister packs. The profile frames integrity not as soft virtue but as hard public-health infrastructure.
Why Kenyan readers should care
Kenya’s pharmacies and informal markets are not immune. Porous borders, online sellers and price pressure create openings for falsified antibiotics, antimalarials and lifestyle drugs. Patients who cannot afford brand originals are most exposed.
Regulators need laboratory capacity, customs cooperation and whistleblower protection — the same toolkit Akunyili fought for under harder conditions.
Practical takeaway
Buy from licensed pharmacies, scrutinise packaging and batch numbers, and report suspected fakes. Policy-wise, fund post-market surveillance and prosecute big suppliers, not only street hawkers.
Health regulators: directory.
Feature synthesis for Kenyan readers; not a biography reprint.